Clinical Trials Directory

Trials / Conditions / Venous Thromboses

Venous Thromboses

28 registered clinical trials studyying Venous Thromboses — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitinginDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Under
NCT06581965
Leiden University Medical CenterPhase 4
Not Yet RecruitingTRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism
NCT06452342
University Health Network, TorontoPhase 4
CompletedExercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome
NCT05794932
University Hospital, MontpellierN/A
RecruitingClonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NCT05711173
University Hospital, BordeauxN/A
RecruitingThe GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
NCT05489588
W.L.Gore & AssociatesN/A
UnknownRisk Factors and Prediction Model of Cancer-associated Venous Thromboembolism
NCT05729464
Yongsheng Jiang—
WithdrawnOsciPulse D-dimer Efficacy Trial
NCT05389488
OsciFlex LLCPhase 2
UnknownEvaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
NCT05449808
Al-Esraa University College—
Active Not RecruitingThe GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05409976
W.L.Gore & AssociatesN/A
WithdrawnThe Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
NCT05246943
The University of Texas Medical Branch, Galveston—
CompletedEvaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow
NCT05087108
OsciFlex LLCEARLY_Phase 1
Active Not RecruitingLeiden Thrombosis Recurrence Risk Prevention
NCT06087952
Leiden University Medical CenterN/A
CompletedClotting Parameters After Medical Abortion
NCT04824118
NHS Lothian—
CompletedRivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
NCT05515120
Instituto Mexicano del Seguro SocialPhase 2 / Phase 3
CompletedRisk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
NCT04439383
Insel Gruppe AG, University Hospital Bern—
CompletedIntermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
NCT04367831
Columbia UniversityPhase 4
CompletedRisk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
NCT04374617
Hospital Universitari Vall d'Hebron Research Institute—
TerminatedAspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients W
NCT04128956
University of ZurichPhase 2
Unknown3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement
NCT03738488
Fundación Pública Andaluza para la gestión de la Investigación en SevillaN/A
CompletedThe Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort St
NCT03835780
Momentum Data—
CompletedFearon Algorithm in Warfarin Patient Self-Management
NCT03911661
University of UtahN/A
WithdrawnBRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis
NCT03613402
Portola Pharmaceuticals—
CompletedAssessment of the Impact of TIP Score on Thromboprophylaxis in Patients With Non-surgical Lower Leg Trauma.
NCT03089255
University Hospital, Angers—
CompletedComparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin
NCT03611894
Centre Hospitalier Universitaire, Amiens—
CompletedIntermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis
NCT04341272
Baltimore VA Medical CenterN/A
WithdrawnValidation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chroni
NCT01810237
Nova Scotia Health AuthorityN/A
CompletedPharmacogenetic Dosage Algorithm for Acenocoumarol
NCT03015025
Instituto de Investigación Hospital Universitario La Paz—
UnknownEducation Program for Patients Receiving Oral Anticoagulation
NCT01339611
University of Sao PauloN/A